Skip to content
Dx

ICD-10-CM 2027 diagnosis code

E11.3293Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral

✓ Billable / specificRequires 7th character

E11.3293 is a valid, billable ICD-10-CM code for type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Type 2 diab with mild nonp rtnop without macular edema, bi

Code last changed in FY2017 (effective October 1, 2016). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About E11.3293

E11.3293 is the ICD-10-CM diagnosis code for type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. It belongs to category E11 (type 2 diabetes mellitus), block E08-E13 (diabetes mellitus) and chapter 4 (endocrine, nutritional and metabolic diseases). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

The 7th character "3" means bilateral.

Use an additional code to identify control using: injectable non-insulin antidiabetic drugs (Z79.85), insulin (Z79.4), oral antidiabetic drugs (Z79.84) and oral hypoglycemic drugs (Z79.84).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 008 (Simultaneous Pancreas, Islet Cell and Kidney Transplant, relative weight 5.5146), DRG 010 (Pancreas or Islet Cell Transplant, relative weight 7.5259), DRG 019 (Simultaneous Pancreas, Islet Cell and Kidney Transplant with Hemodialysis, relative weight 7.5493), DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in Pre-MDC and MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It was added in FY2017, effective October 1, 2016.

Before ICD-10, this condition was coded in ICD-9-CM as 250.50 (diabetes with ophthalmic manifestations, type II or unspecified type, not stated as uncontrolled) and 362.04 (mild nonproliferative diabetic retinopathy).

7th character

3bilateral

Other encounter types for E11.329:

Notes that apply from higher levels

Instructions written at a parent level also apply to E11.3293.

› From E11 Type 2 diabetes mellitus
Includes
  • diabetes (mellitus) due to insulin secretory defect
  • diabetes NOS
  • insulin resistant diabetes (mellitus)
Excludes1
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
Use additional code
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

Broader instructions also apply from Chapter 4: Endocrine, nutritional and metabolic diseases.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 250.50Diabetes with ophthalmic manifestations, type II or unspecified type, not stated as uncontrolledapproximate, combination
  • 362.04Mild nonproliferative diabetic retinopathyapproximate, combination

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2017 (effective 10/1/2016): Added
  • No changes since FY2017.

Common questions about E11.3293

Is E11.3293 billable?

Yes. E11.3293 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

What does the "3" at the end of E11.3293 mean?

It is the 7th character for bilateral.

Can E11.3293 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict E11.3293 as a principal diagnosis.

Is E11.3293 a CC or MCC?

No. E11.3293 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does E11.3293 group to?

E11.3293 is used in the MS-DRG v44.0 logic for MS-DRG 008 (Simultaneous Pancreas, Islet Cell and Kidney Transplant), MS-DRG 010 (Pancreas or Islet Cell Transplant), MS-DRG 019 (Simultaneous Pancreas, Islet Cell and Kidney Transplant with Hemodialysis), MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for E11.3293?

The CMS General Equivalence Mappings map E11.3293 to ICD-9-CM 250.50 and 362.04.